High risk with these micro-cap names ... but it looks good here.
This entry and SL is based on my technical analysis only. Do your research and trade on your own risk!
big movement in the premarket today. is it able to go up to 2,35 again?
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve...
Watch for a break of 1.29, Stop signal 1.14. First target 1.66. Second target momentum. If open range were bullish i would look for a lower entry yet things are still 50/50 until we get that signal.
Corbus 1.Price held to support and did not break 61.8% retracement level from the bottom 2. A push to 1.30 and retracement to confirm the long entry 3. Will be in my watchlist for the coming week
This company sold off because they said they were cutting 54% of their workers to help with cash flow into 2022 during the coronavirus pandemic. The market has clearly priced that in, and I honestly think it's long term bullish! Less employees: less people to pay out! CRBP has a lot of potential upside (more than likely not anytime soon), however, they have the...
Just a bit of the bigger picture on this cheap stock. Good luck folks.
FDA phase 3 failure led to a massive dump. As we know, every reaction in the market is an over-reaction, so get in while it is cheap, or wait and see. Maybe selling puts here could be the correct action. Best of luck.
CORRECCIÓN DEL POST PUBLICADO AYER. Mal visto ayer el movimiento que está haciendo el precio aunque tampoco se descarta totalmente pero veo más posible una continuación de la tendencia alcista. Se puede ver como se ha formado un soporte y parece continuar la tendencia alcista. CORBUS
Esperando correción del precio, MA 15 Y 50, osciladores neutros (MACD, RSI, RVGI)
First I would like to start by saying that we are looking for a major bottom in pot stocks. Corbus Pharmaceuticals is one stock in the weed sector, which is already showing signs of a lasting low in place near 3.30 and overall leading to the upside along with Aurora and Apharia. The first piece of evidence is the upside break of the descending price channel that...